DATATRAK International, Inc. 10-Q
Securities and Exchange Commission
Washington, D.C. 20549
Form 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended March 31, 2008
Commission file number 000-20699
DATATRAK International, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
|
|
34-1685364 |
|
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer |
incorporation or organization)
|
|
Identification No.) |
|
|
|
6150 Parkland Boulevard |
|
|
Mayfield Heights, Ohio
|
|
44124 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
(440) 443-0082
(Registrants telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. þ Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer þ
|
|
Non-accelerated filer o (Do not check if a smaller reporting company)
|
|
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule
12b-2). o Yes þ No
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of
the latest practical date.
The number of Common Shares, without par value, outstanding as of April 30, 2008 was 13,716,901.
TABLE OF CONTENTS
Part I. Financial Information
Item 1 Financial Statements
DATATRAK INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
|
|
(Unaudited) |
|
|
(Note A) |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
3,445,342 |
|
|
$ |
1,919,316 |
|
Short-term investments |
|
|
2,505,518 |
|
|
|
6,595,045 |
|
Accounts receivable, net |
|
|
1,395,989 |
|
|
|
1,070,688 |
|
Deferred tax asset current |
|
|
71,200 |
|
|
|
71,200 |
|
Prepaid expenses and other current assets |
|
|
378,204 |
|
|
|
451,222 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
7,796,253 |
|
|
|
10,107,471 |
|
Property and equipment |
|
|
|
|
|
|
|
|
Equipment |
|
|
2,657,580 |
|
|
|
2,663,021 |
|
Software |
|
|
6,327,162 |
|
|
|
6,325,496 |
|
Leasehold improvements |
|
|
696,571 |
|
|
|
696,571 |
|
|
|
|
|
|
|
|
|
|
|
9,681,313 |
|
|
|
9,685,088 |
|
Less accumulated depreciation |
|
|
6,467,244 |
|
|
|
6,150,289 |
|
|
|
|
|
|
|
|
|
|
|
3,214,069 |
|
|
|
3,534,799 |
|
Other assets |
|
|
|
|
|
|
|
|
Restricted cash |
|
|
93,349 |
|
|
|
87,021 |
|
Deferred tax asset |
|
|
1,230,500 |
|
|
|
1,327,800 |
|
Deposit |
|
|
39,549 |
|
|
|
39,549 |
|
Other intangible assets, net of accumulated amortization |
|
|
333,808 |
|
|
|
520,458 |
|
Goodwill |
|
|
10,856,113 |
|
|
|
10,856,113 |
|
|
|
|
|
|
|
|
|
|
|
12,553,319 |
|
|
|
12,830,941 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
23,563,641 |
|
|
$ |
26,473,211 |
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
594,314 |
|
|
$ |
415,415 |
|
Notes payable |
|
|
251,541 |
|
|
|
246,627 |
|
Current portion of long-term debt |
|
|
3,000,000 |
|
|
|
425,304 |
|
Accrued expenses |
|
|
1,599,717 |
|
|
|
1,607,261 |
|
Deferred revenue |
|
|
1,007,121 |
|
|
|
1,277,276 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
6,452,693 |
|
|
|
3,971,883 |
|
Long-term liabilities |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
182,541 |
|
|
|
3,252,962 |
|
Deferred revenue long-term |
|
|
1,575,000 |
|
|
|
1,680,000 |
|
Deferred tax liability |
|
|
916,700 |
|
|
|
999,000 |
|
|
|
|
|
|
|
|
Total long-term liabilities |
|
|
2,674,241 |
|
|
|
5,931,962 |
|
Shareholders equity |
|
|
|
|
|
|
|
|
Serial Preferred Shares, without par value, 1,000,000 shares authorized, none issued |
|
|
|
|
|
|
|
|
Common Shares, without par value, authorized 25,000,000 shares; issued 17,016,901
shares as of March 31, 2008 and 17,016,901 shares as of December 31, 2007;
outstanding 13,716,901 shares as of March 31, 2008 and 13,716,901 shares as of
December 31, 2007 |
|
|
79,723,600 |
|
|
|
79,618,366 |
|
Treasury Shares, 3,300,000 shares at cost |
|
|
(20,188,308 |
) |
|
|
(20,188,308 |
) |
Common Share warrants |
|
|
1,191,284 |
|
|
|
1,191,284 |
|
Accumulated deficit |
|
|
(46,002,087 |
) |
|
|
(43,769,202 |
) |
Foreign currency translation |
|
|
(287,782 |
) |
|
|
(282,775 |
) |
|
|
|
|
|
|
|
Total shareholders equity |
|
|
14,436,707 |
|
|
|
16,569,366 |
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
23,563,641 |
|
|
$ |
26,473,211 |
|
|
|
|
|
|
|
|
|
|
|
Note A: |
|
The condensed consolidated balance sheet at December 31, 2007 has been derived from the
audited consolidated financial statements at that date, but does not include all of the
information and footnotes required by accounting principles generally accepted in the United
States for complete financial statements. |
See notes to condensed consolidated financial statements.
2
DATATRAK INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Revenue |
|
$ |
2,088,229 |
|
|
$ |
3,542,095 |
|
|
|
|
|
|
|
|
|
|
Direct costs |
|
|
933,879 |
|
|
|
1,337,471 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
1,154,350 |
|
|
|
2,204,624 |
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
2,856,600 |
|
|
|
3,422,671 |
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
522,426 |
|
|
|
622,403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(2,224,676 |
) |
|
|
(1,840,450 |
) |
|
|
|
|
|
|
|
|
|
Interest income |
|
|
59,740 |
|
|
|
70,192 |
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
66,567 |
|
|
|
98,669 |
|
|
|
|
|
|
|
|
|
|
Other loss |
|
|
1,382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(2,232,885 |
) |
|
|
(1,868,927 |
) |
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
26,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,232,885 |
) |
|
$ |
(1,895,227 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
Net loss per share |
|
$ |
(0.16 |
) |
|
$ |
(0.16 |
) |
|
|
|
|
|
|
|
Weighted-average shares outstanding |
|
|
13,681,901 |
|
|
|
11,858,949 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
Net loss per share |
|
$ |
(0.16 |
) |
|
$ |
(0.16 |
) |
|
|
|
|
|
|
|
Weighted-average shares outstanding |
|
|
13,681,901 |
|
|
|
11,858,949 |
|
|
|
|
|
|
|
|
See notes to condensed consolidated financial statements.
3
DATATRAK INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(2,232,885 |
) |
|
$ |
(1,895,227 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
522,426 |
|
|
|
622,403 |
|
Stock-based compensation |
|
|
105,231 |
|
|
|
136,057 |
|
Accretion of discount on investments |
|
|
(42,031 |
) |
|
|
(35,282 |
) |
Other |
|
|
1,382 |
|
|
|
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(321,597 |
) |
|
|
351,551 |
|
Prepaid expenses and other current assets |
|
|
75,280 |
|
|
|
106,320 |
|
Deferred taxes, net |
|
|
15,000 |
|
|
|
26,300 |
|
Accounts payable and accrued expenses |
|
|
141,424 |
|
|
|
(284,839 |
) |
Deferred revenue |
|
|
(375,155 |
) |
|
|
63,120 |
|
|
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(2,110,925 |
) |
|
|
(909,597 |
) |
Investing activities |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(7,350 |
) |
|
|
(47,787 |
) |
Maturities of short-term investments |
|
|
18,600,000 |
|
|
|
4,500,000 |
|
Purchases of short-term investments |
|
|
(14,468,443 |
) |
|
|
(11,820,028 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
4,124,207 |
|
|
|
(7,367,815 |
) |
Financing activities |
|
|
|
|
|
|
|
|
Proceeds from exercise of stock option and warrants |
|
|
|
|
|
|
30,384 |
|
Proceeds from issuance of common shares, net of paid issuance costs |
|
|
|
|
|
|
8,916,105 |
|
Payments of long-term debt |
|
|
(490,811 |
) |
|
|
(364,747 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
(490,811 |
) |
|
|
8,581,742 |
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
3,555 |
|
|
|
(21,241 |
) |
|
|
|
|
|
|
|
Increase in cash and cash equivalents |
|
|
1,526,026 |
|
|
|
283,089 |
|
Cash and cash equivalents at beginning of period |
|
|
1,919,316 |
|
|
|
3,019,184 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
3,445,342 |
|
|
$ |
3,302,273 |
|
|
|
|
|
|
|
|
Unpaid share issuance costs |
|
$ |
|
|
|
$ |
189,028 |
|
|
|
|
|
|
|
|
See notes to condensed consolidated financial statements.
4
DATATRAK INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2008
(Unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of DATATRAK
International, Inc. and subsidiaries (DATATRAK or the Company) have been prepared in accordance
with accounting principles generally accepted in the United States for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by accounting principles
generally accepted in the United States for complete financial statements. In the opinion of
management, all adjustments (consisting of normal recurring accruals) considered necessary for a
fair presentation have been included. Operating results for the three month period ended March 31,
2008 are not necessarily indicative of the results that may be expected for the year ending
December 31, 2008. For further information, refer to the consolidated financial statements and
footnotes thereto included in the Companys Form 10-K for the year ended December 31, 2007.
The preparation of financial statements in conformity with accounting principles generally
accepted in the United States requires management to make estimates and assumptions that might
affect the amounts reported in the financial statements and accompanying notes. Actual results
could differ from those estimates.
2. Risks and Uncertainties
On February 13, 2006, the Company acquired all of the outstanding stock of ClickFind, Inc.
(ClickFind), a company focused on the application of a unified technology platform for clinical
trials. A portion of the purchase price consisted of $4,000,000 in notes payable (ClickFind
Notes). As of May 8, 2008, the Company has a remaining balloon payment obligation under the
ClickFind Notes in the amount of $3,000,000 that is due and payable February 1, 2009. Of the
$3,000,000, $1,963,000 is held by an executive officer of the Company who was the founder of
ClickFind. Of the remaining $1,037,000 of the ClickFind Notes, $763,000 is held by other current
employees of the Company. The Company is continuing its efforts to renegotiate the payment terms
for these notes. If the Company is not successful in renegotiating the payment terms with the note
holders, or if the Company cannot obtain additional funding to meet this obligation, DATATRAK
believes that it will not have available funds to meet the entire $3,000,000 obligation on February
1, 2009.
3. Fair Value Measurements
On January 1, 2008, the Company adopted the provisions of Statement of Financial Accounting
Standards (FAS) No. 157, Fair Value Measurements as required for financial assets and
liabilities. The adoption of FAS No. 157 had no material impact on the Companys financial
position, results of operations or cash flows during the three months ended March 31, 2008. FAS
No. 157 was effective January 1, 2008 for financial assets and liabilities and will be effective
January 1, 2009 for non-financial assets and liabilities. The standard provides guidance for
establishing a frame work for measuring fair values of assets and liabilities. Under the standard,
fair value refers to the price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at the measurement date (i.e. an
exit price). The standard clarifies the principle that fair value should be based on the
assumptions or inputs market participants would use when pricing the asset or liability. In support
of this principle, FAS No. 157 establishes a three level hierarchy for fair value measurements
based on the quality or transparency of inputs used to measure the fair value of an asset or
liability at the measurement date.
The three levels are defined as follows:
|
|
Level 1 (the highest priority) inputs to the valuation methodology are quoted market
prices (unadjusted) for identical financial assets or liabilities in active markets. |
|
|
|
Level 2 inputs to the valuation methodology include quoted market prices for similar
assets and liabilities in active markets, and inputs that are
observable for an asset or
liability, either directly or indirectly, for substantially the full
term of a financial
instrument. |
|
|
|
Level 3 (the lowest priority) inputs to the valuation methodology are unobservable and
significant to the fair value measurement. These inputs reflect managements own assumptions
about the assumptions a market participant would use in pricing a financial instrument. |
5
A financial instruments categorization within the valuation hierarchy is based upon the
lowest level or priority of input that is significant to the fair value measurement of the
financial asset or liability.
The Companys only financial assets or liabilities subject to FAS No. 157 are its investments
in cash equivalents and short-term investment instruments consisting primarily of corporate
obligations in the form of commercial paper, grade A1 or better. Following is a description of the
valuation methodologies used to determine the fair value of the Companys financial assets
including the general classification of such instruments pursuant to the valuation hierarchy.
Cash equivalents - The Company considers all highly liquid investments with a maturity of
three months or less when purchased to be cash equivalents. The Companys cash equivalents consist
of various money market funds. The money market funds are recorded based on quoted market prices
in active markets multiplied by the number of shares owned. The money market funds are classified
in Level 1 of the valuation hierarchy.
Short-term investments The Companys short-term investments consist primarily of corporate
obligations in the form of commercial paper of the highest grade which have maturities of one year
or less. There is a active market for these commercial paper securities at quoted market prices
determined by the issuer of the commercial paper. The short-term investments are classified in
Level 1 of the valuation hierarchy.
The following table presents the financial instruments carried at fair value as of March 31,
2008 by caption on the consolidated balance sheet and by FAS No. 157 valuation hierarchy as
described above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at |
|
|
|
|
|
|
|
Reporting Date Using |
|
|
|
|
|
|
|
Quoted Prices |
|
|
Significant |
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
|
Markets for |
|
|
Observable |
|
|
Unobservable |
|
Description |
|
March 31, 2008 |
|
|
Identical Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
|
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
Cash Equivalents -
Money Market Funds |
|
$ |
1,992,000 |
|
|
$ |
1,992,000 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term
Investments -
Corporate
Obligations
(Commercial Paper)
and Corporate Stock |
|
|
2,506,000 |
|
|
|
2,506,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,498,000 |
|
|
$ |
4,498,000 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4. Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Net loss used in the calculation of basic and diluted earnings per share |
|
$ |
(2,232,885 |
) |
|
$ |
(1,895,227 |
) |
|
|
|
|
|
|
|
Denominator for basic net loss per share weighted-average common shares outstanding |
|
|
13,681,901 |
|
|
|
11,858,949 |
|
Effect of dilutive common share options and warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted net loss per share |
|
|
13,681,901 |
|
|
|
11,858,949 |
|
|
|
|
|
|
|
|
Basic net loss per share |
|
$ |
(0.16 |
) |
|
$ |
(0.16 |
) |
|
|
|
|
|
|
|
Diluted net loss per share |
|
$ |
(0.16 |
) |
|
$ |
(0.16 |
) |
|
|
|
|
|
|
|
Weighted-average common share options and warrants excluded from the computation of
diluted net loss per share because they would have an anti-dilutive effect on net
loss per share |
|
|
1,486,933 |
|
|
|
1,548,463 |
|
|
|
|
|
|
|
|
6
5. Comprehensive Loss
The following table sets forth comprehensive loss.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Net loss |
|
$ |
(2,232,885 |
) |
|
$ |
(1,895,227 |
) |
Foreign currency translation |
|
|
(5,007 |
) |
|
|
(18,464 |
) |
|
|
|
|
|
|
|
Comprehensive loss |
|
$ |
(2,237,892 |
) |
|
$ |
(1,913,691 |
) |
|
|
|
|
|
|
|
6. Shareholders Equity
There are 343,423 warrants outstanding at March 31, 2008 which have original terms of 5 years
and exercise prices ranging from $3.20 to $6.00 per share. Of the 343,423 warrants outstanding,
15,680 with an exercise price of $3.20 per share are scheduled to expire in August 2008.
During the three months ended March 31, 2008, no options were exercised, 6,750 options
expired, 42,711 options were canceled and 42,000 options were granted.
In March 2007, the Company completed a private placement financing with a group of
institutional investors. In connection with this financing, the Company sold 1,986,322 common
shares at a price of $4.75 per share. The terms of the financing included the issuance of five-year
warrants to purchase a total of 297,948 common shares at $6.00 per share to investors in the
private placement, and the issuance of five-year warrants to purchase a total of 29,795 common
shares at $6.00 per share to the placement agents who assisted the Company in the private
placement. The net proceeds from the sale of the common shares were approximately $8,648,000 (after
deducting offering related expenses). The
proceeds were allocated between common shares and common share warrants based on their relative
fair values. All the warrants are outstanding as of March 31, 2008 and 2007.
In connection with the March 2007 financing, we also granted registration rights for the
purchased common shares and the common shares issuable upon exercise of the warrants. The
registration rights agreement specifies filing and effectiveness deadlines and requires the
Company to, except under certain limited circumstances, keep the registration statement effective
until certain threshold dates. The registration rights agreement also requires the Company to
maintain (e.g. maintenance requirement) a sufficient number of common shares to satisfy all the
warrants if they were exercised now or in the future. DATATRAK has sufficient authorized,
unregistered common shares to permit exercise of the warrants. Accordingly, the Company classified
the warrants as equity instruments at March 31, 2008 and 2007. On April 13, 2007, the Company
filed its S-3 registration statement to register sufficient common shares to cover the purchased
common shares and the common shares issuable upon exercise of the warrants issued as part of the
private placement financing. The registration statement was declared effective on May 14, 2007 by
the Securities and Exchange Commission.
In the event the Company fails to meet a filing, effectiveness or maintenance requirement,
DATATRAK shall pay each holder an amount equal to 1% of the aggregate purchase price. The aggregate
amount of these registration delay payments shall not exceed a total of 10% of the aggregate
purchase price of the shares. The Company believes it is not probable that it will be required to
pay a registration delay payment and thus has not recorded a liability with respect to the
registration payment arrangement.
7. Operating Leases
The Company leases certain office equipment and space. Future minimum lease payments for the
Company under non-cancelable operating leases as of March 31, 2008 are as follows:
|
|
|
|
|
Twelve Months ended March 31, |
|
Amount |
|
2009 |
|
$ |
930,000 |
|
2010 |
|
|
610,000 |
|
2011 |
|
|
555,000 |
|
2012 |
|
|
561,000 |
|
2013 |
|
|
334,000 |
|
Subsequent
to March 31, 2013 |
|
|
|
|
|
|
|
|
|
|
$ |
2,990,000 |
|
|
|
|
|
7
8. Income Taxes
Income tax expense consists of the following:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Current U.S. |
|
$ |
(15,000 |
) |
|
$ |
|
|
Deferred foreign |
|
|
15,000 |
|
|
|
26,300 |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
26,300 |
|
|
|
|
|
|
|
|
A reconciliation of income tax expense at the U.S. federal statutory rate to the effective
income tax rate is as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Income tax benefit at the United States statutory rate |
|
$ |
(759,200 |
) |
|
$ |
(635,400 |
) |
Change in valuation allowance |
|
|
886,600 |
|
|
|
587,800 |
|
Foreign tax credit |
|
|
(115,600 |
) |
|
|
|
|
Change in FIN No. 48 liability |
|
|
(15,000 |
) |
|
|
|
|
Foreign taxes |
|
|
(1,900 |
) |
|
|
26,300 |
|
Non-deductible permanent differences |
|
|
5,100 |
|
|
|
47,600 |
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
26,300 |
|
|
|
|
|
|
|
|
For the three months ended March 31, 2008, the Companys pretax loss was $2,233,000. Due to
uncertainty regarding the realization of the deferred tax asset resulting from this loss, DATATRAK
provided for a full valuation allowance against these deferred tax assets, except for a portion of
the foreign deferred tax asset that is unreserved. The deferred foreign tax provision in 2008 and
2007 resulted from the use of foreign net operating losses to reduce foreign taxable income.
During the first quarter of 2008, the Company received the German tax audit report associated
with the German tax audit of the Companys German subsidiary for the years 2003 through 2005. The
report concluded that the 2003 loss was disallowed and should be classified as a constructive
dividend. As a result, the estimated tax assessment due to the German tax authority was $115,000
and the corresponding FIN No. 48 liability of $130,000 recorded at December 31, 2007 was adjusted
to $115,000 at March 31, 2008.
9. Long-Term Debt
Long-term debt at March 31, 2008 and December 31, 2007 is summarized below:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
Notes payable the ClickFind Notes |
|
$ |
3,000,000 |
|
|
$ |
3,425,000 |
|
Financing agreement with Oracle Credit Corporation (the Oracle Agreement) |
|
|
119,000 |
|
|
|
143,000 |
|
Capital lease agreements with Dell Financial Services (the Dell Agreements) |
|
|
315,000 |
|
|
|
357,000 |
|
|
|
|
|
|
|
|
|
|
|
3,434,000 |
|
|
|
3,925,000 |
|
Less current maturities |
|
|
3,251,000 |
|
|
|
672,000 |
|
|
|
|
|
|
|
|
|
|
$ |
183,000 |
|
|
$ |
3,253,000 |
|
|
|
|
|
|
|
|
The ClickFind Notes are held by certain former shareholders of ClickFind. They bear interest
at prime plus 1% and the remaining balloon principal payment of $3,000,000 is due on February 1,
2009. Of the $3,000,000, $1,963,000 is held by an executive officer of the Company who was the
founder of ClickFind. Of the remaining $1,037,000 of ClickFind Notes, $763,000 is held by other
current employees of the Company.
In connection with the Datasci claim, an arrangement was entered into with certain former
ClickFind shareholders for sharing of the expenses associated with that litigation. Under that
arrangement, a certain portion of principal payments due under the notes would be used to offset a
certain portion of the expenses related to the litigation. The two $500,000 principal payments due
on February 1, 2007 and 2008 were partially offset by $79,000 and $75,000, respectively, for
expenses related to the Datasci litigation. In July 2007, DATATRAK settled its litigation related
to Datascis patent infringement claim with no liability against the Company
The Oracle Agreement is for the purchase of certain computer equipment. The terms of the
financing agreement require DATATRAK to make 36 monthly payments of $9,000, including accrued
interest, beginning in July 2006 through June 2009.
8
The Dell Agreements are for the purchase of certain computer equipment. The terms of the lease
agreements require DATATRAK to make monthly payments, currently totaling $16,000, for the 36 month
term of each lease. Certain of these leases include bargain purchase options while the more recent
ones entered into include fair value purchase options at the end of the lease term.
The Oracle Agreement and the Dell Agreement transactions totaling $87,000 for the first three
months of 2007 are excluded from the Companys condensed consolidated statement of cash flows.
There were no such agreements entered into during the first three months of 2008.
10. Employee Terminations
Significant employee terminations took place in the second, third and fourth quarters of 2007.
As a result, the Company accrued severance charges for severance benefits and stay bonuses due to
terminated employees in those periods. Reconciliations of the Companys accrued
severance balances for the first quarters ended March 31, 2008 and 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
Accrued Severance |
|
|
|
Reconciliation |
|
Description |
|
2008 |
|
|
2007 |
|
Accrued severance at 12/31 |
|
$ |
523,000 |
|
|
$ |
7,000 |
|
First quarter charges |
|
|
29,000 |
|
|
|
|
|
First quarter payments |
|
|
(224,000 |
) |
|
|
(7,000 |
) |
|
|
|
|
|
|
|
Accrued severance at 3/31 |
|
$ |
328,000 |
|
|
$ |
|
|
|
|
|
|
|
|
|
The Company accounts for termination benefits in accordance with SFAS No. 146, Accounting
for the Cost of Exit or Disposal Activities which requires that termination benefit expenses be
recorded ratably over the period during which employees must provide future services in order to
obtain the benefit.
11. Restricted Cash
The Companys wholly owned subsidiary, DATATRAK GmbH, is required to provide a bank guarantee
to the lessor of its office space equal to three months of rent. The terms of the bank guarantee
require DATATRAK GmbH to maintain a restricted cash balance of 59,000 euros with the bank. The U.S.
dollar equivalent of this amount was $93,000 at March 31, 2008 and $87,000 at December 31, 2007.
The higher balance at March 31, 2008 compared to December 31, 2007 is solely due to currency
fluctuation.
12. Software Development Costs
Development costs incurred in the research and development of new software products and
enhancements to existing software products are expensed as incurred until technological feasibility
has been established. After technological feasibility is established, any additional costs are
capitalized in accordance with SFAS No. 86, Accounting for the Costs of Computer Software to be
Sold, Leased, or Otherwise Marketed. Such costs are amortized over the lesser of three years or
the economic life of the related product. The net carrying value for capitalized software
development costs was $2,351,000 and $2,504,000 as of March 31, 2008 and December 31, 2007,
respectively. The Company performs a review of the recoverability of such capitalized software
costs when impairment indicators arise. At the time a determination is made that capitalized
amounts are not recoverable based on the estimated cash flows to be generated from the applicable
software, any impairment amounts are expensed.
Research and development expenses included in selling, general and administrative expenses
were $471,000 and $669,000 for the three months ended March 31, 2008 and 2007, respectively.
13. Goodwill and Finite-Lived Tangible and Intangible Assets
As a result of consecutive quarterly operating losses since the first quarter of 2006 and
forecasted continuing operating losses based on current sales trends, the Company determined that
impairment indicators existed as of March 31, 2008. The Company conducted interim impairment
testing of its goodwill and finite-lived tangible and intangible assets as of this date and
determined that no impairment occurred.
14. Reclassification
Certain prior year amounts have been reclassified to conform to the current year presentation.
9
15. Contingencies
In the ordinary course of business, the Company is involved in employment related legal
proceedings. The Company is of the opinion that the ultimate resolution of these matters will not
have a material adverse effect on the results of operations, cash flows or the financial position
of DATATRAK.
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
The information set forth and discussed below for the three month period ended March 31, 2008
is derived from, and should be read in conjunction with, the condensed consolidated financial
statements included elsewhere herein. The financial information set forth and discussed below is
unaudited, but in the opinion of management, reflects all adjustments (consisting of normal
recurring accruals) necessary for a fair presentation of such information. The Companys results of
operations for a particular quarter may not be indicative of results expected during the other
quarters or for the entire year.
General
DATATRAK is a provider of software and other related services, commonly referred to as an
application service provider, or ASP. DATATRAKs customers use the software known as DATATRAK
EDC(R) and DATATRAK eClinical(TM) to collect and transmit clinical trial data, commonly referred to
as electronic data capture, or EDC. The Companys services assist companies in the clinical
pharmaceutical, biotechnology, contract research organization and medical device industries, in
accelerating the completion of clinical trials. Approximately 25% of the Companys assets, or
$5,951,000, is held in cash, cash equivalents and short-term investments, and goodwill accounts for
approximately 46% or, $10,856,000, of the Companys total assets. The Company is continuing to
enhance and commercialize its business and software, and anticipates that its operating results may
fluctuate significantly from period to period. There can be no assurance of the Companys long-term
future prospects. Our future success is dependent on market acceptance of EDC in general as an
alternative to the traditional paper method of collecting clinical trial data and acceptance of our
software products specifically.
On February 13, 2006, we acquired all of the outstanding stock of ClickFind, a company focused
on the application of a unified technology platform for clinical trials, located in Bryan, Texas.
As a result of the acquisition, we believe we have the most extensive software suite in the
clinical trials industry. A portion of the purchase price consisted of $4,000,000 in notes payable
(ClickFind Notes) with principal payments due in installments of $500,000, $500,000 and
$3,000,000 on February 1, 2007, 2008 and 2009, respectively. As of May 8, 2008, the Company has a
remaining balloon payment obligation under the ClickFind Notes in the amount of $3,000,000 that is
due and payable February 1, 2009. The Company is continuing its efforts to renegotiate the payment
terms for these notes. If we are unable to renegotiate the ClickFind Notes or raise additional
capital we do not believe we will be able to meet our February 1, 2009 obligation, which would have
a material adverse effect on our business, financial condition and results of operations. Of the
$3,000,000 outstanding ClickFind Notes payable balance, $1,963,000 is held by an executive officer
of the Company who was the founder of ClickFind and of the remaining $1,037,000, $763,000 is held
by other current employees of the Company.
DATATRAK recognizes revenue in accordance with Staff Accounting Bulletin 104, Revenue
Recognition and Emerging Issues Task Force (EITF) Issue No. 00-21, Revenue Arrangements with
Multiple Deliverables. The Company recognizes revenue when all of the following criteria are met:
persuasive evidence of an arrangement exists; delivery of the product or service has occurred; the
fee is fixed or determinable; and collectibility is probable. DATATRAKs contracts provide a fixed
price for each element to be delivered, and revenue is recognized as these multiple-elements are
delivered. The Company determines the price of items included in multiple-element arrangements
using objective, reliable evidence of fair value. This evidence is based on the vendor-specific per
element price the Company would sell an item for on a standalone basis or other methods allowable
under EITF No. 00-21. DATATRAK recognizes revenue based on the performance or delivery of the
following specified services or components of its contracts in the manner described below:
|
|
|
Enterprise license revenue is recognized ratably over the life of the license
agreement. |
|
|
|
|
Project management and data management (design, report and export) service revenue
is recognized proportionally over the life of a contract as services are performed,
based on the contractual billing rate per hour for those services. |
|
|
|
|
Data items revenue is earned based on a price per data unit as data items are
entered into our hosting facility. |
|
|
|
|
Classroom training services revenue is recognized as classroom training is
completed, at rates based on the length of the training program. |
10
|
|
|
Internet-based training services revenue is recognized on a per user basis as
self-study courses are completed. |
|
|
|
|
Help desk revenue is recognized based on a monthly price per registered user or
site under the contract. |
Services provided by us that are in addition to those provided for in our contracts are billed
on a fee for service basis as services are completed. Costs associated with contract revenue are
recognized as incurred. Costs that are paid directly by our clients, and for which we do not bear
the risk of economic loss, are excluded from revenue. The termination of a standard contract will
not result in a material adjustment to the revenue or costs previously recognized.
Backlog consists of anticipated revenue from authorization letters to commence services and
signed contracts yet to be completed. Potential contracts or authorization letters that have passed
the verbal stage, but have not yet been signed, are excluded from backlog. At March 31, 2008,
DATATRAKs backlog was $13,894,000 compared to $13,040,000 at December 31, 2007. DATATRAKs
individual trial contracts can be cancelled or delayed at anytime. Approximately 80% of the
Companys March 31, 2008, backlog is individual contracts and subject to being cancelled or delayed
at anytime. The Companys individual contract backlog, at any point in time, is not an accurate
predictor of future levels of revenue. As a result of DATATRAKs transactional and service-based
business model combined with the dynamic nature of the clinical trials market where changes in
scope are common, backlog has historically not been an accurate predictor of short-term revenue.
Critical Accounting Policies
In response to the SECs Release No. 33-8040, Cautionary Advice Regarding Disclosure About
Critical Accounting Policies, we have identified the most critical accounting principles upon
which our financial status depends. Critical principles were determined by considering accounting
policies that involve the most complex or subjective decisions or assessments. The most critical
accounting policies were identified to be those related to revenue recognition, software
development costs, stock-based compensation, goodwill and finite-lived tangible and intangible
assets and income taxes.
A summary of the Companys critical accounting policies related to revenue recognition,
software development costs, stock-based compensation, goodwill and finite-lived tangible and
intangible assets and income taxes can be found in the Companys Annual Report on Form 10-K, filed
on March 17, 2008, (Annual Report) under the heading Critical Accounting Policies in
Managements Discussion and Analysis of Financial Condition and Results of Operations.
Results of Operations
Three months ended March 31, 2008 compared with three months ended March 31, 2007
Revenue for the three months ended March 31, 2008 decreased $1,454,000, or 41.1%, to
$2,088,000, as compared to $3,542,000 for the three months ended March 31, 2007. During the first
quarter of 2008, DATATRAK recorded revenue related to 93 contracts compared to 122 contracts during
the three months ended March 31, 2007. For the three months ended March 31, 2008, $1,734,000 of
revenue was the result of contracts that were in backlog at December 31, 2007, $201,000 was the
result of new business signed since January 1, 2008, and $153,000 was the result of contracts
acquired from ClickFind. During the first quarter of 2008, the Company commenced two significant
multi-year enterprise license agreements and recognized $138,000 of revenue from those agreements.
The Company will continue to recognize revenue on these enterprise license agreements ratably over
the life of each respective license period. For the first quarter of 2007, $3,181,000 of revenue
was generated from contracts that were in backlog at December 31, 2006, $119,000 of revenue was the
result of new business signed since January 1, 2007, and $242,000 was the result of contracts
acquired from ClickFind. The reduction in revenue for the three months ended March 31, 2008,
compared to the same prior year three month period was also impacted by a significant decrease
attributable to one client, Otsuka Research Institute, which accounted for 5% of our total revenue
in the first quarter of 2008 compared to 24% of total revenue in the first quarter of 2007. We
believe less than 10% of our total 2008 revenue will come from Otsuka.
We have previously disclosed that we have experienced significant trial delays from certain
clients during the second half of 2007 regarding nine trials. In the 2008 first quarter, one client
with two of the nine delayed trials canceled both trials. As a result of these cancellations, we
reduced our backlog by approximately $900,000. We will be required to refund approximately $220,000
of unearned start-up fees in 2008 related to these cancellations. Also in the 2008 first quarter,
another client with two of the nine delayed trials entered into an $800,000 three-year enterprise
agreement with us. As part of the agreement, the two delayed trials were exchanged with two current
trials resulting in a minimal increase to backlog. We increased our backlog by $800,000 in the 2008
first quarter for the enterprise agreement. The remaining five delayed trials represent $1,297,000
of our March 31, 2008, backlog of $13,894,000, or approximately 9%. We expect at least one of the
five trials to begin generating revenue in 2008.
11
We experienced
significant turnover in our sales team during 2007, however, we continue our efforts to enhance our sales and marketing organization. Six of the Companys current ten person sales
and marketing staff have been with DATATRAK approximately a year or less. The Company replaced its
Vice President of Marketing and Sales in June 2007 and added a Director of Marketing in the third
quarter of 2007 to aggressively pursue sales growth in future periods.
Direct costs of revenue, mainly personnel costs, were $934,000 and $1,337,000 during the three
months ended March 31, 2008 and 2007, respectively. The net decrease of $403,000, or 30.2%, was
primarily due to lower payroll and benefit costs of $361,000. DATATRAKs gross margin decreased
to 55.3% for the three months ended March 31, 2008 compared to 62.2% for the three months ended
March 31, 2007 primarily as a result of a 41.1% decrease in revenue. Gross margin was unfavorably
impacted by a higher exchange rate between the U.S. dollar and the euro compared to the first
quarter of 2007. Direct costs for our German subsidiary, primarily wages, are paid in euro and
converted to U.S. dollars for consolidated financial reporting purposes using the average exchange
rate for the period. Our gross margin would have been 56.8% for the first quarter of 2008, compared
to the actual 55.3%, had the exchange rate between the U.S. dollar and the euro remained constant
year-over-year. Approximately 30% of our direct costs are subject to exchange rate fluctuation
between the U.S. dollar and the euro. The average exchange rate between the U.S. dollar and the
euro increased from approximately 1.310 in the first quarter of 2007 to approximately 1.498 in the first quarter of
2008. Additional increases in the exchange rate between the U. S. dollar and the euro will have an
adverse effect on our financial condition and our results of operations for 2008 as compared to
2007.
Selling, general and administrative expenses (SG&A) include all administrative personnel
costs, business and software development costs, and all other expenses not directly chargeable to a
specific contract. SG&A expenses decreased by $566,000, or 16.5% to $2,857,000 from $3,423,000 for
the three months ended March 31, 2008 and 2007, respectively. Staff and other payroll costs
decreased $210,000 primarily as a result of staff reductions. In addition, advertising and travel
expenses decreased $237,000 for the three months ended March 31, 2008 compared to the same period
ended March 31, 2007 primarily as a result of eliminating certain marketing programs.
SG&A expenses were unfavorably impacted by $57,000 as a result of a higher exchange rate
between the U.S. dollar and the euro compared to the first quarter of 2007. Approximately 15% of
our SG&A expenses are subject to exchange rate fluctuation between the U.S. dollar and the euro.
The average exchange rate between the U.S. dollar and the euro increased from approximately 1.310
in the first quarter of 2007 to approximately 1.498 in the first quarter of 2008. Additional
increases in the exchange rate between the U. S. dollar and the euro will have an adverse effect on
our financial condition and our results of operations for 2008 as compared to 2007.
Depreciation and amortization expense decreased $100,000, or 16.1%, from $522,000 for the
three months ended March 31, 2008 compared to $622,000 for the three months ended March 31, 2007.
The decrease consists of a $40,000 reduction in the amortization on the non-compete intangible
asset and a $60,000 reduction in depreciation expense due to the increasing number of fixed assets
that became fully depreciated since March 2007.
Interest expense decreased by $32,000 to $67,000, in the first quarter of 2008 from $99,000 in
the first quarter of 2007 primarily from a reduction in the ClickFind Notes outstanding principal
balance.
Liquidity and Capital Resources
The Companys principal sources of cash are cash flow from operations and proceeds from the
sale of equity securities. The Companys investing activities primarily reflect capital
expenditures and sales and purchases of short-term investments. Financing activities include debt
repayments on the ClickFind Notes, the financing agreement with Oracle Credit Corporation and the
capital lease agreement with Dell Financial Services.
In March of 2007, we completed a private placement financing with a group of institutional
investors. In connection with this financing, we sold 1,986,322 common shares at a price of $4.75
per share. The terms of this financing included the issuance of five-year warrants to purchase a
total of 297,948 common shares at $6.00 per share to investors in the private placement, and the
issuance of five-year warrants to purchase a total of 29,795 common shares at $6.00 per share to
the placement agents who assisted the Company in the private placement. The net proceeds from the
sale of the common shares were approximately $8,648,000 (after deducting the offering related
expenses).
On December 31, 2007, we received a significant customer receipt in the amount of $2.1 million
from NTT DATA Corporation (NTT) in exchange for a five-year enterprise subscription license
agreement. To date, we have not established a trend of multi-year large dollar subscription license
agreements similar to the $2.1 million deal with NTT DATA Corporation.
Contracts with our customers usually require a portion of the contract amount to be paid at
the time the contract is initiated. Additional payments are generally received monthly as work on
the contract progresses. We record all amounts received as a liability
12
(deferred revenue) until work has been completed and revenue is recognized. Cash receipts do
not necessarily correspond to costs incurred or revenue recognized. We typically receive a low
volume of large-dollar receipts and our accounts receivable will fluctuate due to the timing and
size of cash receipts. Our contracting and collection practices are designed to encourage customer
payment of accounts receivable balances between one to three months from invoice date. Any increase
in our days sales outstanding is an indicator that our cash flow from operations and our working
capital has been negatively impacted. At March 31, 2008, our days sales outstanding was 58 days
as compared with 51 days calculated at December 31, 2007. Trade accounts receivable (net of
allowance for doubtful accounts) was $1,332,000 at March 31, 2008 and $1,018,000 at December 31,
2007. Short-term deferred revenue was $1,007,000 at March 31, 2008 compared to $1,277,000 at
December 31, 2007. Long-term deferred revenue was $1,575,000 at March 31, 2008 compared to
$1,680,000 as of December 31, 2007. The long-term deferred revenue balance is a result of the
$2,100,000 advance payment received in December 2007 upon the signing of a five-year enterprise
subscription license agreement with NTT.
Cash and cash equivalents increased $1,526,000 during the three months ended March 31, 2008.
This was the net result of $2,111,000 used in operating activities, $4,124,000 provided by
investing activities and $491,000 used in financing activities. Net cash used in operating
activities was mainly the net result of our net loss of $2,233,000 and changes in operating assets
and liabilities of $465,000 offset by non-cash depreciation and amortization of $522,000 and
non-cash stock-based compensation of $105,000. Investing activities included $7,000 used to
purchase property and equipment, and current period maturities of short-term investments less
additional investments in short-term investments totaling $4,131,000. Financing activities
primarily consist of debt repayments of $425,000 for the ClickFind Notes and $66,000 for the
repayment of capital equipment lease and financing agreements.
At March 31, 2008, we had working capital of $1,344,000, and our cash, cash equivalents and
short-term investments totaled $5,951,000. Our working capital decreased by $4,792,000 since
December 31, 2007. The decrease was primarily the result of the $2,111,000 of cash used in
operating activities during the first quarter and the reclassification of the ClickFind Notes
balloon payment of $3,000,000 due February 1, 2009 from long-term liabilities to current
liabilities at March 31, 2008.
We are party to a lease agreement that requires us to maintain a restricted cash balance. Our
restricted cash balance was $93,000 at March 31, 2008.
We have established a line of credit with a bank. This line allows us to borrow up to a
certain percentage of the investments, as determined by the type of investment, held at the bank.
As of March 31, 2008, $1,487,000 was available to be borrowed. The line of credit bears interest at
rates based on the prime rate, and is payable on demand. We had no amounts outstanding against
the line of credit at March 31, 2008.
At March 31, 2008, we had a note payable in the amount of $119,000 to Oracle Credit
Corporation, payable in monthly payments of $9,000, including accrued interest through June 2009.
Additionally, at March 31, 2008, we had various capital lease
agreements in the amount of $315,000
with Dell Financial Services, payable in 36 monthly installments currently totaling $16,000,
including accrued interest.
The terms of our acquisition of ClickFind required us to pay approximately $4,000,000 of cash
to the former shareholders of ClickFind in February 2006. We also issued notes payable to the
former shareholders of ClickFind in the amount of $4,000,000 that bear interest at prime plus 1.0%.
The notes payable had an outstanding balance of $3,000,000 as of March 31, 2008 of which the entire
amount is due and payable February 1, 2009. Of the $3,000,000, $1,963,000 is held by an executive
officer of the Company who was the founder of ClickFind. Of the remaining $1,037,000 of ClickFind
Notes, $763,000 is held by other current employees of the Company. The Company is continuing our
efforts to renegotiate the payment terms for the remaining ClickFind Notes. If the Company is not
successful in renegotiating the payment terms with the note holders, DATATRAK believes that it will
not have available funds to meet the $3,000,000 obligation on February 1, 2009.
In July 2007, DATATRAK settled its litigation related to Datascis patent infringement claim
with no liability against the Company. In connection with the Datasci claim, an arrangement was
entered into with certain former ClickFind shareholders for sharing of the expenses associated with
that litigation. Under that arrangement, a certain portion of principal payments due under the
notes would be used to offset a certain portion of the expenses related to the litigation. Of the
$500,000 payment due on February 1, 2007, $79,000 was held by the Company to satisfy these
expenses. Of the $500,000 payment due on February 1, 2008, $75,000 was held by the Company to
satisfy such expenses. A total of $154,000 of the ClickFind Notes were used to offset expenses
associated with the litigation.
We intend to continue to fund the maintenance and testing of the DATATRAK EDC®
software, as well as invest in the development, enhancement and
testing of DATATRAK eClinical(TM).
In 2007, revenue from one major customer had significantly decreased from the prior year. We expect
to have negative cash flow from operations during 2008 as we continue
to transition from
13
dependence on a major customer to a broader customer base with the expansion of our eClinical
product offering. We also expect to record a net loss in 2008. We anticipate expenditures for
property and equipment of approximately $165,000 for 2008, for the continued commercialization,
enhancement and maintenance of our two clinical trial product offerings as well as improvements to
our internal operating systems. We anticipate financing approximately half of the $165,000 total
property and equipment expenditures.
We record our research and development expenditures as part of SG&A expenses. Our research and
development expenditures will be for the maintenance and testing of our DATATRAK EDC®
software and the development, enhancement and testing of our DATATRAK eClinical(TM) software
products. For the first three months ended March 31, 2008, we
expensed approximately $471,000 for
research and development.
If existing sales trends from the past seven months (September 2007 March 2008) continue
for the rest of 2008, and we experience no significant unforeseen trial cancellations or delays, we
believe we will have available funds in order to meet our short-term working capital requirements
through December 31, 2008. However, if existing sales trends from the past seven months continue
for the rest of 2008, even if we experience no significant unforeseen trial cancellations or
delays, we do not believe we will have sufficient available funds in order to meet our longer-term
working capital requirements for 2009, including the $3,000,000 balloon payment on the ClickFind
Notes due February 1, 2009. At March 31, 2008, we had working capital of $1,344,000. In an effort
to partially address these working capital needs, we made significant cost reductions during the
fourth quarter of 2007 which we expect will yield an annual cost savings of approximately $2.1
million. On an ongoing basis in 2008, we will implement additional cost cutting measures if revenue
and sales trend performance falls below our minimum expectations and we are unable to obtain
additional funding. In addition to the fourth quarter cost savings moves, we are continuing our
efforts to restructure the ClickFind Notes. During 2007 the German tax authority began an audit of
the Companys German subsidiary for the fiscal years 2002 through 2005. In the fourth quarter of
2007, the German tax authority established a position to disallow losses recognized in 2003 and
characterized such losses as constructive dividends to the U.S. parent company. During the second
quarter of 2008 we will be required to make an estimated $615,000 payment to the German tax
authority of which we expect approximately $500,000 to be refunded within one to three months from
the time we pay the tax and file the refund claim. Any delay or non-payment of the $500,000
expected refund will have an adverse impact on our business, financial condition and results of
operations. Any increase in the 2008 average exchange rate between the U.S. dollar and the euro,
as compared to the average 2007 rate, will have an adverse impact on our available cash. We may
also need to raise additional funds to offset delays or cancellations of existing contracts. We may
raise additional funds by selling debt or equity securities, by entering into strategic
relationships or through other arrangements. Additional capital may not be available on acceptable
terms, if at all. To the extent that additional equity capital is raised, it could have a dilutive
effect on our existing shareholders.
Fair Value Measurements
During the first quarter of 2008, the Company adopted the Statement of Financial Accounting
Standards (FAS) No. 157, Fair Value Measurements. The adoption of FAS No. 157 had no material
impact on the Companys financial position, results of operations or cash flows during the three
months ended March 31, 2008. FAS No. 157 was effective January 1, 2008 for financial assets and
liabilities and will be effective January 1, 2009 for non-financial assets and liabilities. The
standard provides guidance for establishing a frame work for measuring fair values of assets and
liabilities. Under the standard, fair value refers to the price that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date (i.e. an exit price). The standard clarifies the principle that fair value should
be based on the assumptions or inputs market participants would use when pricing the asset or
liability. In support of this principle, FAS No. 157 establishes a three level hierarchy for fair
value measurements based on the quality or transparency of inputs used to measure the fair value of
an asset or liability at the measurement date. For details on the Companys adoption of FAS No.
157 for financial assets and liabilities, see Note 3 Fair Value Measurements to our Condensed
Consolidated Financial Statements.
Inflation
To date, the Company believes the effects of inflation have not had a material adverse effect
on its results of operations or financial condition.
Information About Forward-Looking Statements
Certain statements made in this Form 10-Q, other SEC filings, written materials or orally by the
Company or its representatives may constitute forward-looking statements that are based on
managements current beliefs, estimates and assumptions concerning the operations, future results
and prospects of the Company and the clinical pharmaceutical research industry in general. All
statements that address operating performance, events or developments that management anticipates
will occur in the future, including statements related to future revenue, profits, expenses, cost
reductions, cash management alternatives, restructuring our debt, raising additional
14
funds, income and earnings per share or statements expressing general optimism about future
results, are forward-looking statements within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended (Exchange Act). In addition, words such as expects,
anticipates, intends, plans, believes, estimates, variations of such words, and similar
expressions are intended to identify forward-looking statements. Forward-looking statements are
subject to the safe harbors created in the Exchange Act. Factors that may cause actual results to
differ materially from those in the forward-looking statements include the limited operating
history on which the Companys performance can be evaluated; the ability of the Company to continue
to enhance its software products to meet customer and market needs; fluctuations in the Companys
quarterly results; the viability of the Companys business strategy and its early stage of
development; the timing of clinical trial sponsor decisions to conduct new clinical trials or
cancel or delay ongoing trials; the Companys dependence on major customers; government regulation
associated with clinical trials and the approval of new drugs; the ability of the Company to
compete in the emerging EDC market; losses that potentially could be incurred from breaches of
contracts or loss of customer data; the inability to protect intellectual property rights or the
infringement upon others intellectual property rights; delisting of Companys common shares from
the Nasdaq due to our failure to continue to meet applicable Nasdaq Capital Market requirements;
the Companys success in integrating ClickFinds operations into its own operations and the costs
associated with maintaining and/or developing two product suites; and general economic conditions
such as the rate of employment, inflation, interest rates and the condition of capital markets.
This list of factors is not all inclusive. In addition, the Companys success depends on the
outcome of various strategic initiatives it has undertaken, all of which are based on assumptions
made by the Company concerning trends in the clinical research market and the health care industry.
Any forward-looking statement speaks only as of the date on which such statement is made and the
Company does not undertake any obligation to update any statements whether as a result of new
information, future events or otherwise.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The Company is exposed to market risk from changes in interest rates and foreign currency
exchange rates since it funds its operations through short-term investments, has issued variable
rate debt and has business transactions in euros. A summary of the Companys market risk exposures
is presented below.
Interest Rate Risk
DATATRAK has fixed income investments consisting of cash equivalents and short-term
investments, and short-term notes payable which may be affected by changes in market
interest rates. The Company does not use derivative financial instruments in its investment
portfolio. The Company places its cash equivalents and short-term investments with high-quality
financial institutions, limits the amount of credit exposure to any one institution and has
established investment guidelines relative to diversification and maturities designed to maintain
safety and liquidity. A 1.0 percentage point change in interest rates during the three months
ended March 31, 2008, would have resulted in a $18,000 change in DATATRAKs interest income during
the period.
The Companys notes payable to certain former shareholders of ClickFind bear interest at prime
plus 1%, and interest is paid quarterly. A 1.0 percentage point change in the prime rate during the
three months ended March 31, 2008, would have resulted in a $8,000 change in DATATRAKs interest
expense during the period.
Foreign Currency Risk
DATATRAKs foreign results of operations are subject to the impact of foreign currency
fluctuations through both foreign currency transaction and foreign currency translation
adjustments. The Company manages its risk to foreign currency transaction adjustments by
maintaining foreign currency bank accounts in currencies in which we regularly transact business.
DATATRAK does not currently hedge against the risk of exchange rate fluctuations.
DATATRAKs financial position and results of operations are impacted by translation
adjustments caused by the conversion of foreign currency accounts and operating results into U.S.
dollars for financial reporting purposes. A 1.0% fluctuation in the exchange rate between the U.S.
dollar and the euro at March 31, 2008, would have resulted in a $500 change in the foreign currency
translation amount recorded on the Companys balance sheet, due to foreign currency translations. A
1.0% fluctuation in the average exchange rate between the U.S. dollar and the euro for the three
months ended March 31, 2008, would have resulted in a $7,000 change in the Companys net loss for
the three months ended March 31, 2008, due to foreign currency transactions. During the three
months ended March 31, 2008, the average exchange rate between the euro and the U.S. dollar
increased by approximately 14.3% compared to the three months ended March 31, 2007. The conversion
of the Companys foreign operations into U.S. dollars upon consolidation resulted in a net loss
that was approximately $90,000 more than would have been recorded had the exchange rate between the
euro and the U.S. dollar remained consistent with 2007 first quarter rates.
15
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company carried out an evaluation, under the supervision and with the participation of the
Companys management, including the chief executive officer and chief financial officer, of the
design and operation of the Companys disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-14(e)) as of the end of the period covered by this report. Based upon
that evaluation the Companys management, including the chief executive officer and chief financial
officer, have concluded that, as of March 31, 2008, the Companys disclosure controls and
procedures were effective to ensure that information required to be disclosed by the Company in the
reports it files and submits under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the SECs rules and forms.
Changes in Internal Controls
There were no changes in the Companys internal controls over financial reporting that
occurred during the fiscal quarter covered by this report that have materially affected, or are
reasonably likely to materially affect, the Companys internal controls over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
In the ordinary course of business, we are involved in employment related legal proceedings.
We are of the opinion that the ultimate resolution of these matters will not have a material
adverse effect on the results of operations, cash flows or the financial position of the Company.
Item 1A. Risk Factors
Except
for the new Risk Factor set forth below, there are no material
changes to the Risk Factors previously disclosed in the
Companys Annual Report on Form 10-K for the fiscal year
ended December 31, 2007.
If we fail to continue to meet all applicable Nasdaq Capital Market requirements, our common shares
could be delisted. If delisting occurs, it would adversely affect the market liquidity of our
common shares and harm our businesses.
Our common shares are currently traded on the Nasdaq Capital Market under the symbol DATA. If we
fail to meet any of the continued listing standards of the Nasdaq Capital Market, our common shares
could be delisted from the Nasdaq Capital Market. These continued listing standards include
specifically enumerated criteria, such as:
|
|
a $1.00 minimum closing bid price; |
|
|
|
shareholders equity of $2.5 million, market value of publicly-held shares of $35
million, or net income from continuing operations of $500,000 in the most recently
completed fiscal year or in two of the last three most recently completed fiscal years; |
|
|
|
500,000 shares of publicly-held common stock with a market value of at least $1 million; |
|
|
|
300 round-lot shareholders; and |
|
|
|
compliance with Nasdaqs corporate governance requirements, as well as additional or
more stringent criteria that may be applied in the exercise of Nasdaqs discretionary
authority. |
For the
nine consecutive trading days up to and including May 9, 2008,
the Closing Bid price of our common shares
was below $1.00. Nasdaq rules requires that the minimum closing bid price of a common share be
at least $1.00. If for 30 consecutive trading days the closing bid price of our common shares does
not increase to at least $1.00, Nasdaq will promptly notify us of our non-compliance. To regain
compliance, the closing bid price of our common shares would have to remain at $1.00 or more for a
minimum of ten consecutive trading days during the 180-day period following Nasdaqs notice.
If we do not regain compliance during this first 180-day period, Nasdaq will determine whether we
meet the Nasdaq Capital Market initial listing criteria, except for the minimum closing bid price
requirement. If at that time we meet the initial listing criteria (currently we do meet the
initial listing criteria, except for the minimum closing bid price requirement), we will be
eligible for an
16
additional 180-day cure period. If we are not eligible for the additional cure period or if we do
not achieve compliance during the additional 180-day cure period, Nasdaq will provide us with
written notification that our common shares will be delisted. We will have the right to appeal
Nasdaqs delisting determination to a Listing Qualifications Panel.
The 180-day cure period described above relates exclusively to our minimum closing bid price
deficiency. We may be delisted during the 180-day period for failure to maintain compliance with
any other continued listing requirements that occur during this period. Even if we are successful
in curing a non-compliance, Nasdaq may seek to delist us for our failure to meet the enumerated
conditions for continued listing.
If our common shares are delisted from the Nasdaq Capital Market, trading of our common shares most
likely will be conducted in the over-the-counter market on an electronic bulletin board established
for unlisted securities, such as the Pink Sheets or the OTC Bulletin Board. Such delisting could
also adversely affect our ability to obtain financing for the continuation of our operations and
could result in the loss of confidence by customers and shareholders.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Submission of Matters to a Vote of Security Holders
None.
Item 5. Other Information
None.
Item 6. Exhibits
10.1 |
|
Employment Agreement between the Company and Raymond J. Merk effective April 14, 2008 |
|
10.2 |
|
Form of Nonqualified Stock Option Agreement for Outside Directors |
|
31.1 |
|
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer |
|
31.2 |
|
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer |
|
32.1 |
|
Section 1350 Certification of Chief Executive Officer |
|
32.2 |
|
Section 1350 Certification of Chief Financial Officer |
17
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
DATATRAK International, Inc.
Registrant
|
|
Date: May 12, 2008 |
/s/ Jeffrey A. Green
|
|
|
Jeffrey A. Green, |
|
|
President and Chief Executive Officer and a Director
(Principal Executive Officer) |
|
|
|
|
|
Date: May 12, 2008 |
/s/ Raymond J. Merk
|
|
|
Raymond J. Merk |
|
|
Vice President of Finance, Chief Financial Officer
(Principal Financial and Accounting Officer) |
|
18